Abstract
Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell non-Hodgkin lymphoma with an aggressive fatal course and it has varied clinical presentation with an uncommon presentation when they present as soft tissue masses or when there is spill in the peripheral blood or there are composite lymphomas that are rare presentations. Common presentations include lymphadenopathy, fever and systemic symptoms, hemolytic anemias, skin rashes, and rheumatoid arthritis. The classical histopathology is absence of follicles in lymph nodes with presence of high endothelial venules and the tumor cells of small to medium-sized lymphocytes with pale cytoplasm mixed with reactive T cells. On immunohistochemistry, the cells are positive for CD3, CD4, CD10, BCL2, and CXCL13. In this observational study, the clinicopathologic presentation and the immunohistochemical profile of five cases who initially presented with a soft tissue mass which is an extremely rare presentation of this rare type of non-Hodgkin lymphoma that was diagnosed at our center with peripheral blood and bone marrow involvement and the clinicopathologic presentation, immunohistochemical profile, and response to treatment on follow-up are correlated with the literature review. One case had a fulminant and aggressive course and was fatal within 2 months of diagnosis. The rest of the four cases are on regular chemotherapy and follow-up. Our five cases had presented with soft tissue masses, two in the axillary regio,n two in the hand, and one in the scapular region with an extranodal presentation, and there was associated lymphadenopathy which developed subsequently with classic histomorphology and immunohistochemical findings. The age range was 46–54 years and all five cases were males. Three cases were with anemia (hemoglobin range 6.5–8.0 mg/dl) and all five cases were having peripheral blood plasmacytosis. Histopathology was classic with paracortical involvement with polymorphous population of cells with neoplastic lymphocytes of small and large sizes with numerous arborizing blood vessels which correspond to high endothelial venules. Microscopically, three architectural patterns; pattern I was seen in three cases (60%) and then pattern II and III in one case each (20% each). Immunohistochemistry revealed CD4+, CD8−, CXCL13+, CD10+, BCL6+, CD19, CD20, CD1a, Tdt, CD21, and CD23+ in follicular dendritic cells. AITL is a rare and aggressive non-Hodgkin lymphoma with varied clinical presentation with classic histomorphology with various patterns which may cause diagnostic dilemma and immunophenotypic findings, and prompt and early diagnosis is mandatory for institution of therapy.
Similar content being viewed by others
References
Jaffe ES, Ralfkiaer E (2001) Angioimmunoblastic T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H et al (eds) World Health Organization classification of tumors. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. IARC Press, Lyon, pp 225–226
Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B et al (2013) Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the International Peripheral T-cell Lymphoma Project. J Clin Oncol 31(2):240–246
Frizzera G, Moran EM, Rappaport H (1974) Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1:1070–1073
Lachenal F, Berger F, Ghesquires H et al (2007) Angio-immunoblastic lymphoma. Clinical and laboratory features at diagnosis in 77 patients. Medicine 86:282–292
Attygale A, Al Jehani R, Diss TC et al (2002) Neoplastic T cells in angio-immunoblastic lymphoma express CD10. Blood 99:627–633
Dupuis J, Boye K, Martin N et al (2006) Expression of CXCL13 by neoplastic cells in angio-immunoblastic T cell lymphoma (AITL):a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 86:490–494
Dunleavy K, Wilson WH, Jaffe ES (2007) Angio-immunoblastic lymphoma. Pathological insights and clinical implications. Curr Opin Hematol 14:348–353
Pangalis GA, Moran EM, Nathwani BN, Zelman RJ, Kim H et al (1983) Angioimmunoblastic lymphoma. Long-term follow-up study. Cancer 52:318–321
Iannitto E, Ferreri AJ, Minardi V, Tripodo C, Kreipe HH (2007) Angio-immunoblastic lymphoma. Crit Rev Oncol Hematol 68:264–271
de Leval L, Gisselbrecht C, Gaulard P (2010) Advances in the understanding and management of angio-immunoblastic lymphoma. Br J Hematol 148:673–689
Rodriguez-Justo M, Attygale AD, Munson P, Roncador G, Marafioti T, Piris MA (2009) Angio-immunoblastic lymphoma with hyperplastic germinal centers: a neoplasia with origin in the outer zone of the germinal center? Clinicopathological and immunohistological study of 10 cases with follicular T cell markers. Mod Pathol 22:753–761
Suefuji N, Niino D, Arakawa F, Karube K, Kimura Y, Kiyasu J et al (2012) Clinicopathological analysis of a composite lymphoma containing both T and B cell lymphomas. Pathol Int 62:690–698
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mukherjee, T., Dutta, R. & Pramanik, S. Aggressive Angioimmunoblastic T Cell Lymphomas (AITL) with Soft Tissue Extranodal Mass Varied Histopathological Patterns with Peripheral Blood, Bone Marrow, and Splenic Involvement and Review of Literature. Indian J Surg Oncol 9, 11–14 (2018). https://doi.org/10.1007/s13193-017-0657-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-017-0657-y